Galen Growth is pleased to share with you our latest report on the Digital Health ecosystem in the Asia Pacific in 2021. We focus our analysis on the ecosystem key trends, through the lens of noteworthy deals, exits, and partnerships executed in the past 12 months. In 2021, a record of $8.7B of venture funding was deployed across 317 deals, an increase of 11.2% as compared to 2020 and a new record.
With unmatched, unparalleled and indispensable coverage of the global Digital Health ecosystems, this report is powered by HealthTech Alpha, a Galen Growth proprietary solution, and the world’s leading on-demand Digital Health private market data, analytics and intelligence platform. For more information, visit https://www.healthtechalpha.com/
Digital Health ventures mentioned in the report include:
Miaoshou (妙手医生), Gene+ (吉因加), XtalPi (晶泰科技), Medlinker (医联), Keep (Keep), harrison.ai, Synyi.ai (森亿智能), Xbiome (未知君), PharmEasy, Yaoshibang (药师帮), Shukun (数坤科技), Creative Biosciences (康立明生物), HealthifyMe, XtalPi (晶泰科技),, MediTrust Health (镁信健康), Yaoshibang (药师帮), Insilico Medicine, ddky (叮当快药), Klinify, Doctor Raksa, Sasta Sundar, AndMe, GP2U Telehealth, Genie Solutions, MedicalDirector, BabyChakra, Sweat App, ChunLab (천랩), Yidu Cloud (医渡科技), ExaWizards (エクサウィザーズ), Microtech Medical (微泰医疗), Basecare Medical (贝康医疗), Airdoc (Airdoc), Gu Sheng Tang Zhong Yi (固生堂), Goodwill (嘉和美康), Vuno (뷰노), Geninus (지니너스), Advanced Human Imaging, LPixel (エルピクセル), WeDoctor (微医), Halodoc, Lunit (루닛), Plano, Docon, Docquity, DoctorOnCall, mClinica, Deepwise (深睿医疗), Linkedcare (领健), GV20 Oncotherapy (寻百会), Bepluslab (비플러스랩)